ARS Wealth Advisors Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.71M Buy
2,261
+11
+0.5% +$11.2K 0.21% 59
2026
Q1
$2.07M Buy
2,250
+102
+5% +$103K 0.17% 64
2025
Q4
$2.31M Sell
2,148
-94
-4% -$89.9K 0.21% 56
2025
Q3
$1.71M Buy
2,242
+49
+2% +$36.5K 0.17% 63
2025
Q2
$1.71M Buy
2,193
+78
+4% +$60.6K 0.2% 61
2025
Q1
$1.75M Buy
2,115
+2
+0.1% +$1.66K 0.25% 52
2024
Q4
$1.63M Buy
2,113
+27
+1% +$22.4K 0.22% 53
2024
Q3
$1.85M Buy
2,086
+20
+1% +$18K 0.23% 55
2024
Q2
$1.87M Buy
2,066
+44
+2% +$35.2K 0.24% 52
2024
Q1
$1.57M Sell
2,022
-19
-0.9% -$13.5K 0.21% 55
2023
Q4
$1.19M Buy
2,041
+124
+6% +$72.4K 0.18% 56
2023
Q3
$1.03M Buy
1,917
+89
+5% +$45.9K 0.17% 65
2023
Q2
$857K Sell
1,828
-375
-17% -$157K 0.14% 71
2023
Q1
$757K Buy
2,203
+370
+20% +$125K 0.14% 70
2022
Q4
$671K Sell
1,833
-5,401
-75% -$1.91M 0.11% 76
2022
Q3
$2.34M Hold
7,234
0.36% 58
2022
Q2
$2.35M Buy
7,234
+667
+10% +$200K 0.32% 68
2022
Q1
$1.88M Sell
6,567
-64
-1% -$16.5K 0.33% 45
2021
Q4
$1.83M Buy
6,631
+101
+2% +$25.6K 0.31% 44
2021
Q3
$1.51M Buy
+6,530
New +$1.61M 0.27% 46

Other funds holding LLY

ARS Wealth Advisors Group's LLY Position: Q2 2026 in Review

ARS Wealth Advisors Group increased its Eli Lilly (LLY) stake by 0.49% in Q2 2026, buying an estimated $11.2K and bringing the position to 2,261 shares worth $2.71M. The position accounts for 0.21% of the portfolio, ranked #59.

ARS Wealth Advisors Group first reported a position in LLY in Q3 2021 and has held it in 20 quarters since. 1,863 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • ARS Wealth Advisors Group held 2,261 shares of Eli Lilly worth $2.71M as of Q2 2026.
  • ARS Wealth Advisors Group bought 11 Eli Lilly shares in Q2 2026, an estimated $11.2K.
  • Eli Lilly made up 0.21% of ARS Wealth Advisors Group's portfolio in Q2 2026, its #59 holding.
  • ARS Wealth Advisors Group first reported a position in Eli Lilly in Q3 2021 and has held it in 20 quarters since.
  • 1,863 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on ARS Wealth Advisors Group's 13F filing for Q2 2026, filed 16 Jul 2026.